SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending as the market reacts to the company's latest subscription price hikes, which analysts view as a strategic move to fund a massive content budget and solidify profitability. While some retail investors are voicing frustration over recurring cost increases, the community is heavily focused on the stock's relative strength and technical breakout potential, with many discussing its role as a hedge against broader market volatility.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is rallying as investors react to a strategic $14.2 billion deal to regain full ownership of its Ireland-based Fab 34, a move perceived as a major vote of confidence in the company's manufacturing and AI-driven growth trajectory. The community is actively debating the stock's future, with many interpreting the heavy capital reinvestment as a clear indicator that major new customer contracts are imminent.

Soleno Therapeutics, Inc. operates as clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It focuses on the treatment of metabolic and neurobehavioral disorder. It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.

Soleno Therapeutics Inc

Soleno Therapeutics is trending following the recent FDA approval of its rare disease drug, VYKAT XR, which has triggered intense market activity and discussions regarding the company's valuation, potential for a future buyout, and its ability to execute a successful commercial launch. Investors and traders are closely monitoring price action as the company transitions into a commercial-stage entity, with active debate surrounding its long-term growth prospects versus risks of dilution or volatility.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending due to heightened speculation surrounding a potential buyout, as market participants monitor recent biotech deal flow and comments from industry observers. While some investors focus on the company's robust obesity drug pipeline and late-stage clinical progress, others are actively debating the impact of competitive GLP-1 developments and broader macroeconomic volatility on its near-term valuation.

“Buttcoin - The Next Bitcoin” is the memecoin version of Bitcoin. Launched on January 30, 2025, on Pump.fun, it’s a community-owned memecoin on Solana. The idea was inspired by a 4:20 minutes long YouTube video from 2013 called "The Next Bitcoin?" by James D. McMurray.

The Next Bitcoin

Investors are rallying behind this Solana-based meme coin as a satirical movement intended to mock established market structures, with community members actively comparing its long-term potential to industry giants. Discussions are currently dominated by enthusiasts promoting the token's cultural narrative and its goal of creating viral engagement within the broader crypto ecosystem.

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.

Neurocrine Biosciences, Inc.

Neurocrine Biosciences is trending as the market reacts to the definitive agreement to acquire Soleno Therapeutics for $2.9 billion. Community sentiment is mixed, with active debate regarding whether the acquisition effectively addresses Neurocrine's need for pipeline growth or if the premium paid for the rare-disease asset signals a strategic overpay.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is currently trending as shareholders analyze the strategic implications of parent company Centurium Capitals acquisition of Blue Bottle Coffee. While the community remains divided over potential conflicts of interest versus synergistic growth, investors are closely monitoring for signs of a long-anticipated U.S. exchange relisting and are actively debating the stock's future valuation amid shifting institutional ownership.

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Altria Group Inc.

Altria Group is seeing significant investor interest driven by a combination of resilient pricing power in its core smokeable business and ongoing momentum in its smoke-free portfolio, particularly with the growth of its on! nicotine pouches. The community is actively debating the company's long-term pivot from traditional cigarettes toward smoke-free alternatives, with many highlighting the stock's role as a classic, high-yield defensive play in a volatile market.

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company, which engages in the genetic epilepsies into the development of therapies for central nervous system, or CNS, disorders characterized by neuronal excitation-inhibition imbalance. It focuses on two proprietary platforms: Cerebrum and Solidus. The Cerebrum platform utilizes a deep understanding of neuronal excitability and neuronal networks and applies a series of computational and experimental tools to develop orally available precision therapies. The Solidus platform consists of antisense oligonucleotide, or ASO. The company was founded by Kiran Reddy, David Goldstein, and Steven Petrou on September 22, 2015 and is headquartered in Boston, MA.

Praxis Precision Medicines Inc

Praxis Precision Medicines is experiencing a significant surge in momentum as the company reports positive trial results for its essential tremor and epilepsy therapies, driving multiple analyst price target upgrades. While the community is debating the impact of a recent large-scale public offering, many investors remain bullish on the long-term potential of the company's CNS-focused pipeline.

CareCloud, Inc. is a healthcare information technology company, which engages in the provision of an integrated suite of proprietary cloud-based electronic health records and practice management solutions. It operates through the Healthcare IT and Practice Management segments. The Healthcare IT segment offers a proprietary web-based suite of services such as practice management applications, certified electronic health records solutions, revenue cycle management services and mobile health applications. The Practice Management segment provides medical practices as well as telemedicine, management, bill-paying and financial advisory services. The company was founded by Mahmud Haq in 1999 and is headquartered in Somerset, NJ.

CareCloud Inc - 8.75% PRF PERPETUAL USD 25 - Ser B

CareCloud Inc. series B preferred stock is gaining investor attention as the company shifts toward a double-dividend payment structure in the coming year, driving community discussions around potential capital appreciation and yield. While some investors remain focused on the income opportunity and broader debt-reduction strategies, others are closely monitoring listing compliance and management's ongoing efforts to streamline the capital structure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Figma shares dropped 8% on Wednesday.</li><li>The updated Stitch packs several functionalities generally found in high-end design platforms such as Figma.</li><li>Retail traders on Stocktwits remained ‘bearish’ on FIG amid recent weak stock performance.</li></ul>Figma on Wednesday became the latest casualty of AI companies increasingly encroaching on the turf held by niche software firms. Shares of the company plunged 8%, its steepest fall in over a month, after Google updated its AI design tool, Stitch, with sophisticated capabilities.&nbsp;<h2 class="st-heading-2">Stitch Targets Figma’s Turn</h2>Stitch, first launched in May last year as an experimental tool for designing UI elements for web and mobile apps, can&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/GoogleLabs/status/2034337527293944228">now turn</a> natural language prompts into high-fidelity UI designs, support voice edits, and build interactive prototypes.The update makes it more friendly to users with little coding or design experience. Users can input business objectives or describe the desired user experiences to generate design concepts, removing the need to start on traditional wireframes.Powered with an AI agent, Stitch can now track the entire project histories, convert static designs into clickable prototypes, and preview app flows – capabilities generally found in high-end design platforms such as Figma.Stitch runs on Gemini models with generous free limits – 350 generations monthly in standard mode – and exports directly to Figma or code like React. Although only more testing would reveal overlaps with Figma, tech observers and investors&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/i/trending/2034472461274611899">largely viewed</a> the updated Stitch tool as a threat to the company.&nbsp;<h2 class="st-heading-2">AI Rollout Hammers Niche Software Stocks&nbsp;</h2>The drop in <a href="https://stocktwits.com/symbol/FIG">Figma stock</a> echoes a familiar pattern. Over the past two months, shares of major software firms such as Intuit and Salesforce, along with several cybersecurity names, have declined instantly following Anthropic’s rollout of new capabilities in its Claude “Cowork” agentic AI platform that would overlap with core use cases served by these companies.The development comes at a challenging time for Figma, which debuted on the New York Stock Exchange in July, a year after its merger with Adobe was shelved due to regulatory hurdles.The stock had rallied a staggering 250% on its opening day but has since declined sharply. It’s currently down 23% from its IPO price. On Stocktwits, retail sentiment for FIG has tracked in the ‘bearish’ zone since the start of this month.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/next-lng-vg-us-lng-shares-rise-as-qatar-attack-threatens-key-export-hub/cZ3aemMRIWl">NEXT, LNG, VG: US LNG Shares Rise As Qatar Attack Threatens Key Export Hub</a>&nbsp;

The Figma AI logo is seen displayed on a smartphone screen. 

Figma Shares Plunge After Google Revamps AI Design Tool Stitch

Google’s Stitch can generate high-fidelity UI designs with natural language prompts, supports voice edits, and builds interactive prototypes – making it very easy for users with limited design or coding skills.

Is Google’s AI Tool Coming For Figma? FIG Stock Drops As Stitch Gets Smarter

Equity

Google’s Stitch can generate high-fidelity UI designs with natural language prompts, supports voice edits, and builds interactive prototypes – making it very easy for users with limited design or coding skills.


Canva has launched an employee stock sale valuing the Australian design software startup at $42 billion, a jump of more than 30% from its $32 billion valuation in 2024.&nbsp;Employees will be able to sell shares to new and existing investors, including Fidelity Management &amp; Research and JPMorgan Asset Management, Bloomberg&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-08-20/canva-begins-share-sale-at-42-billion-valuation-in-road-to-ipo">reported</a>.The firm, founded in 2013, is betting on artificial intelligence to drive growth and position itself for a potential IPO.&nbsp;In April, Canva rolled out AI-powered features such as a conversation-based photo editor to target corporate clients and compete with Adobe, which is developing its own Firefly AI model, and Figma, valued at $34 billion after its July listing.“This round has been significantly oversubscribed,” said co-founder and COO Cliff Obrecht, calling it a strong vote of confidence in Canva’s momentum and future scale.&nbsp;The company&nbsp;boasts of&nbsp;$3.3 billion in annualized sales and over 240 million monthly active users.Canva, led by CEO Melanie Perkins, has long been viewed as a top IPO candidate.&nbsp;The employee share sale provides liquidity to staff while keeping the company private, a common approach among high-growth startups to retain and reward talent while attracting outside investors.Retail sentiment toward <a href="https://stocktwits.com/symbol/CANVA">Canva</a> stream set up on Stocktwits was ‘neutral’ amid ‘normal’ message volume.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Canva on App Store displayed on a phone screen is seen in this illustration photo taken in Poland on June 5, 2024. (Photo by Jakub Porzycki/NurPhoto via Getty Images)

Australian Design Software Maker Canva’s Valuation Soars To $42B As Employee Stock Sale Goes ‘Oversubscribed’

Canva has launched an employee stock sale valuing the Australian design software startup at $42 billion, a jump of more than 30% from its $32 billion valuation in 2024. 

Canva’s Valuation Soars To $42B As Employee Stock Sale Goes ‘Oversubscribed’

The design software giant is ramping up AI-powered tools to win over corporate clients and take on rivals Adobe and Figma, fueling talk of a future IPO.

CANVA
Canva

Latest CANVA News

CANVACanva

Latest CANVA News

CANVA
Canva